These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 18828513

  • 1. Preparing and mixing allergen vaccines for subcutaneous immunotherapy.
    Nelson HS.
    Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513
    [No Abstract] [Full Text] [Related]

  • 2. Subcutaneous administration of allergen vaccines.
    Radtke M, Grammer LC.
    Clin Allergy Immunol; 2008; 21():321-32. PubMed ID: 18828514
    [No Abstract] [Full Text] [Related]

  • 3. Administration of sublingual vaccines.
    Passalacqua G, Canonica GW.
    Clin Allergy Immunol; 2008; 21():333-41. PubMed ID: 18828515
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What should drive the choice of allergen for immunotherapy in polysensitized patients?
    Ciprandi G, Incorvaia C, Puccinelli P, Dell'Albani I, Frati F.
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Specific immunotherapy with allergen mixes: what is the evidence?
    Nelson HS.
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
    [Abstract] [Full Text] [Related]

  • 12. Allergen injection immunotherapy.
    Varga EM, Durham SR.
    Clin Allergy Immunol; 2002 Dec; 16():533-49. PubMed ID: 11577558
    [No Abstract] [Full Text] [Related]

  • 13. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [Abstract] [Full Text] [Related]

  • 14. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
    Mohapatra SS, San-Juan-Vergara H, Wopfner N, Ferreira F.
    Clin Allergy Immunol; 2008 Apr; 21():393-413. PubMed ID: 18828519
    [No Abstract] [Full Text] [Related]

  • 15. Adjuvants and vector systems for allergy vaccines.
    Moingeon P, Lombardi V, Saint-Lu N, Tourdot S, Bodo V, Mascarell L.
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [Abstract] [Full Text] [Related]

  • 16. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S.
    Lakartidningen; 2011 May; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract] [Full Text] [Related]

  • 17. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ, Bousquet J.
    Clin Allergy Immunol; 2008 May; 21():343-58. PubMed ID: 18828516
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.